These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9989747)

  • 1. Interferon alfa for chronic hepatitis C infection.
    Delgado Fernández M; Zambrana García JL; Díez García F
    Lancet; 1999 Feb; 353(9151):499-500. PubMed ID: 9989747
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon alfa for chronic hepatitis C infection.
    Kingsley D
    Lancet; 1999 Feb; 353(9151):499; author reply 500. PubMed ID: 9989746
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon in wonderland.
    Koretz RL
    Gastroenterology; 1998 Oct; 115(4):1027-9. PubMed ID: 9786731
    [No Abstract]   [Full Text] [Related]  

  • 4. New interferon alfa formulation licensed for treatment of hepatitis C.
    Thompson CA
    Am J Health Syst Pharm; 2001 Mar; 58(6):452. PubMed ID: 11286138
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic hepatitis C: early intervention.
    Koff RS
    Hosp Pract (1995); 1998 Jun; 33(6):101-5, 108, 111-4. PubMed ID: 9636354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic hepatitis C, autoimmunity and interferon alfa treatment].
    Garcia Buey L; Moreno Otero R
    Rev Esp Enferm Dig; 1999 Mar; 91(3):165-7. PubMed ID: 10348601
    [No Abstract]   [Full Text] [Related]  

  • 7. Urticarial vasculitis caused by hepatitis C virus infection: response to interferon alfa therapy.
    Hamid S; Cruz PD; Lee WM
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 1):278-80. PubMed ID: 9704847
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of alpha 2b versus lymphoblastoid interferon in treatment of chronic hepatitis C. A randomized trial.
    González Sánchez M; Palacios A; Caballero T; Torres Fernández-Piñar C; Bellot V; Ruiz Extremera A; Salmerón J
    Rev Esp Enferm Dig; 1998 Aug; 90(8):553-62. PubMed ID: 9780788
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C.
    Bruchfeld A; Ståhle L; Andersson J; Schvarcz R
    Nephrol Dial Transplant; 2001 Aug; 16(8):1729. PubMed ID: 11477195
    [No Abstract]   [Full Text] [Related]  

  • 10. Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea.
    Schalm SW
    Gut; 1998 Nov; 43(5):602. PubMed ID: 9824337
    [No Abstract]   [Full Text] [Related]  

  • 11. Case report: a patient who developed an amoebic liver abscess during treatment with interferon.
    Matsuo T; Shinzawa H; Sugahara K; Mitsuhashi H; Watanabe H; Abe T; Ohno S; Terashita M; Saito K; Saito T; Misawa H; Togashi H; Takahashi T
    J Gastroenterol Hepatol; 1998 Oct; 13(10):1068-71. PubMed ID: 9835326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of chronic hepatitis C and response to interferon therapy in older patients.
    Hervé S; Savoye G; Riachi G; Capet C; Goria O; Lerebours E; Colin R
    Age Ageing; 2001 Jul; 30(4):355-6. PubMed ID: 11509317
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon treatment of children with chronic hepatitis C.
    al-Tawil Y; Nelson C
    Hepatogastroenterology; 1998; 45(20):345-8. PubMed ID: 9638404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C.
    Downs AM; Dunnill MG
    Clin Exp Dermatol; 2000 Jun; 25(4):351-2. PubMed ID: 10971502
    [No Abstract]   [Full Text] [Related]  

  • 15. LKM1 antibody and interferon therapy in children with chronic hepatitis C.
    Iorio R; Giannattasio A; Vespere G; Vegnente A
    J Hepatol; 2001 Nov; 35(5):685-7. PubMed ID: 11690721
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and treatment of hepatitis C.
    D'Souza R; Foster GR
    J R Soc Med; 2004 May; 97(5):223-5. PubMed ID: 15121811
    [No Abstract]   [Full Text] [Related]  

  • 17. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.
    Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC
    Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of combined interferon and ribavirin for treatment of hepatitis C.
    Brown JL
    Lancet; 1998 Jan; 351(9096):78-9. PubMed ID: 9439486
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of acute hepatitis C with interferon alfa-2b.
    Patel R; Germer JJ
    N Engl J Med; 2002 Apr; 346(14):1091-2. PubMed ID: 11932480
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C.
    Kim WR; Poterucha JJ; Gross JB
    Hepatology; 2000 Mar; 31(3):807-8. PubMed ID: 10722315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.